Literature DB >> 28797184

Late Presentation HIV/AIDS Is Still a Challenge in Brazil and Worldwide.

Shirley V Komninakis1,2, Magaly Lima Mota1, James Richard Hunter2, Ricardo Sobhie Diaz2.   

Abstract

Despite all the efforts to contain the HIV/AIDS epidemics, there still are individuals of unknown diagnosis. These present high risk of mortality and after diagnosis respond very poorly to treatment. Late testing also represents a reduced opportunity in controlling the transmission of HIV and causes an indirect increase in the transmission rates of other diseases, such as tuberculosis. In European countries, as well as in the United States, a great number of people, represented especially by illegal immigrants, black individuals, and women, markedly present at a later state of infection. In 1996, Brazil was the very first developing country to offer free and universal access to antiretroviral therapy, as well as easy access to HIV testing and care. Nonetheless, there is still a significant number of young and adult subjects who look for HIV/AIDS services and hospitals at later stage of infection by HIV (late presenters). Here we discuss important aspects related to the late diagnosis of HIV in Brazil and worldwide.

Entities:  

Keywords:  Brazil; HIV; late presentation

Mesh:

Year:  2017        PMID: 28797184     DOI: 10.1089/AID.2015.0379

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  6 in total

1.  Severe Sporotrichosis Treated with Amphotericin B: A 20-Year Cohort Study in an Endemic Area of Zoonotic Transmission.

Authors:  Vivian Fichman; Dayvison Francis Saraiva Freitas; Antonio Carlos Francesconi do Valle; Rogerio Valls de Souza; André Luiz Land Curi; Cláudia Maria Valete-Rosalino; Priscila Marques de Macedo; Andréa Gina Varon; Maria Helena Galdino Figueiredo-Carvalho; Fernando Almeida-Silva; Rosely Maria Zancopé-Oliveira; Raquel de Vasconcelos Carvalhaes Oliveira; Rodrigo Almeida-Paes; Maria Clara Gutierrez-Galhardo
Journal:  J Fungi (Basel)       Date:  2022-04-30

2.  Epidemiology of HIV, syphilis, and hepatitis B and C among manual cane cutters in low-income regions of Brazil.

Authors:  Déborah Ferreira Noronha de Castro Rocha; Luana Rocha da Cunha Rosa; Carla de Almeida Silva; Brunna Rodrigues de Oliveira; Thaynara Lorrane Silva Martins; Regina Maria Bringel Martins; Marcos André de Matos; Megmar Aparecida Dos Santos Carneiro; Juliana Pontes Soares; Ana Cristina de Oliveira E Silva; Márcia Maria de Souza; Robert L Cook; Karlla Antonieta Amorim Caetano; Sheila Araujo Teles
Journal:  BMC Infect Dis       Date:  2018-11-03       Impact factor: 3.090

3.  Virologic Outcomes Among People Living With Human Immunodeficiency Virus With High Pretherapy Viral Load Burden Initiating on Common Core Agents.

Authors:  Anthony M Mills; Kathy L Schulman; Jennifer S Fusco; Michael B Wohlfeiler; Julie L Priest; Alan Oglesby; Laurence Brunet; Philip C Lackey; Gregory P Fusco
Journal:  Open Forum Infect Dis       Date:  2021-07-09       Impact factor: 3.835

4.  Cognitive and Neuronal Link With Inflammation: A Longitudinal Study in People With and Without HIV Infection.

Authors:  Albert M Anderson; Jeong Hoon Jang; Kirk A Easley; Dietmar Fuchs; Magnus Gisslen; Henrik Zetterberg; Kaj Blennow; Ronald J Ellis; Donald Franklin; Robert K Heaton; Igor Grant; Scott L Letendre
Journal:  J Acquir Immune Defic Syndr       Date:  2020-12-15       Impact factor: 3.731

5.  Kaposi sarcoma among people living with HIV in the French DAT'AIDS cohort between 2010 and 2015.

Authors:  I Poizot-Martin; V Obry-Roguet; C Duvivier; C Lions; T Huleux; C Jacomet; T Ferry; A Cheret; C Allavena; F Bani-Sadr; R Palich; A Cabié; A Fresard; P Pugliese; P Delobel; I Lamaury; L Hustache-Mathieu; S Brégigeon; A Makinson; D Rey
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-04-30       Impact factor: 6.166

6.  Low variation in initial CD4 cell count in a HIV referral center, in Salvador, Brazil, from 2002 to 2015.

Authors:  Marcela Fonseca Pereira; Estela Luz; Eduardo Martins Netto; Manoel Henrique Fonseca Barbosa; Carlos Brites
Journal:  Braz J Infect Dis       Date:  2018-06-06       Impact factor: 3.257

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.